Vanda pharmaceuticals announces presentation at 2025 aan annual meeting

Washington , april 7, 2025 /prnewswire/ -- vanda pharmaceuticals inc. (vanda) (nasdaq: vnda) today announced participation at the american academy of neurology (aan) annual meeting, to be held in san diego, california from april 5 through april 9, 2025.  the following will be presented: april 9, 2025   presentation title: "translating ighmbp2 variants with a cmt2s patient-specific organ-on-a-chip model: personalized medicine aso-based therapeutic rescue" poster presentation session: p-12 poster number: 11-017 presenter: dr. sandra paulina smieszek, head of genetics this poster describes the data around a novel breakthrough therapeutic (vca-894a) customized to a specific genetic mutation of a patient with charcot-marie-tooth disease type 2s (cmt2s).
AAN Ratings Summary
AAN Quant Ranking